Fully human mAbs for Clostridium difficile infection (Pamlico Biopharma)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFully human mAbs for Clostridium difficile infection (Pamlico Biopharma)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPamlico BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPamlico BioPharma Inc
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A